Year 2020 / Volume 27 / Number 2

PDF HTML

Avances en Dolor

Dimethyl fumarate: from an antipsoriatic drug to a promising antineuropathic drug

Rev. Soc. Esp. Dolor. 2020; 27(2): 74-75 / DOI: 10.20986/resed.2020.3805/2020

Enrique J. Cobos






Complete Article

New comment

Security code:
CAPTCHA code image
Speak the codeChange the code
 

Comments

No comments in this article

References

1. Bomprezzi R. Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview. Ther Adv Neurol Disord. 2015;8(1):20-30. DOI: 10.1177/1756285614564152.
DOI: 10.1177/1756285614564152
2. Ayala-Fontánez N, Soler DC, McCormick TS. Current knowledge on psoriasis and autoimmune diseases. Psoriasis (Auckl). 2016;6:7-32. DOI: 10.2147/PTT.S64950.
DOI: 10.2147/PTT.S64950
3. Grace PM, Gaudet AD, Staikopoulos V, Maier SF, Hutchinson MR, Salvemini D, et al. Nitroxidative Signaling Mechanisms in Pathological Pain. Trends Neurosci. 2016;39(12):862-79. DOI: 10.1016/j.tins.2016.10.003.
DOI: 10.1016/j.tins.2016.10.003
4. Satoh T, Okamoto SI, Cui J, Watanabe Y, Furuta K, Suzuki M, et al. Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophilic phase II inducers. Proc Natl Acad Sci U S A. 2006;103(3):768-73. DOI: 10.1073/pnas.0505723102.
DOI: 10.1073/pnas.0505723102
5. Kappos L, Gold R, Miller DH, Macmanus DG, Havrdova E, Limmroth V, et al. Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. Lancet. 2008;372(9648):1463-72. DOI: 10.1016/S0140-6736(08)61619-0.
DOI: 10.1016/S0140-6736(08)61619-0
6. Patejdl R, Zettl UK. Spasticity in multiple sclerosis: Contribution of inflammation, autoimmune mediated neuronal damage and therapeutic interventions. Autoimmun Rev. 2017;16(9):925-36. DOI: 10.1016/j.autrev.2017.07.004.
DOI: 10.1016/j.autrev.2017.07.004
7. Li J, Ma J, Lacagnina MJ, Lorca S, Odem MA, Walters ET, et al. Oral Dimethyl Fumarate Reduces Peripheral Neuropathic Pain in Rodents via NFE2L2 Antioxidant Signaling. Anesthesiology. 2020;132(2):343-56. DOI: 10.1097/ALN.0000000000003077.
DOI: 10.1097/ALN.0000000000003077
Fornasari D. Pharmacotherapy for Neuropathic Pain: A Review. Pain Ther. 2017;6(Suppl 1):25-33. DOI: 10.1007/s40122-017-0091-4.
DOI: 10.1007/s40122-017-0091-4

Related articles

Citation tools

Cobos E. Dimethyl fumarate: from an antipsoriatic drug to a promising antineuropathic drug. Rev Soc Esp Dolor 2020; 27(2): 74-75 / DOI: 1020986/resed20203805/2020


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics

This article has received 9724 visits.
This article has been downloaded 0 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Accepted: 27/03/2020

Online First: 27/03/2020

Published: 17/04/2020


Share

This article hasn't been rated yet.
Reader rating:
Rate this article:
Send by e-mail
© 2025 Revista de la Sociedad Española del Dolor
ISSN: 1134-8046   e-ISSN: 2254-6189

       Indexed in:
Legal Notice